This is an open session hosted by the National Academy of Sciences, Engineering, and Medicine.  The 1.5-day public workshop to will be held on July 24-25, 2019 in Washington, D.C and focus on the translation of federal investments in biomedical science to innovation in drug development and how the public benefits from that investment in terms of drug pricing and access. The meeting will feature invited presentations and panel discussions on topics that may include:   how federal funding for…

Keynote lecture given by Kevin Outterson, Executive Director of CARB-X. Additional details forthcoming.

The ASM/ECSMID Conference on Drug Development returns to Boston, Massachusetts for 2019. Check back soon for program details. Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by National and International bodies. There are relatively few agents in developmental pipelines and a paucity of identified microbiological targets that can be exploited for drug development. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology…

Online registration will open in spring 2019 - Check back soon for details.

This symposium explores the complex interactions between law and antimicrobial research and development. Advancing our understanding of this ecosystem will help design a better legal toolkit to promote antimicrobial innovation and limit the impact of resistance on global health. Held at the University of Cambridge, an international hub for legal and scientific expertise, we hope the event will mobilize legal, economic, business, medical and scientific experts – early, mid, and late career – who recognize the need to work together…

We are excited to announce that CARB-X will be hosting our first ever CARB-X Developer Conference. The conference will be held on September 6th, 2019 in Boston, immediately following the conclusion of the ASM-ESCMID conference.  Additional details will follow.  Please save the date! This  will be an excellent networking event for CARB-X product developers, who will have the opportunity to connect with and learn from some of the most innovative members of the AMR community, including companies in our diverse portfolio as well as representatives…

Attendees include Richard Alm, CARB-X Alliance Director. IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), and the Pediatric Infectious Diseases Society (PIDS). At IDWeek, you will see familiar colleagues and new faces. IDWeek is a forum for health professionals of varied backgrounds to collaborate, cooperate, and learn from each other’s expertise. With so many common issues and challenges cutting across our four…